Polyolefins for pharmaceutical packaging & medical devices

Repsol offers

  • Gamma and E-beam resistant PP.
  • Specific solutions for BFS applications.
  • Supply to all the regions of the world.
  • 100% recyclable polyolefins.
  • ISCC Plus certification for our polyolefins
  • with chemically recycled content.
  • Bio-based polyolefins.

Our drive

To fulfill our customers’ needs

  • Product reliability and traceability
  • Compliance
  • Long term commitment

Commitment

Dedicated storage facilities and quality management protocols to ensure the highest quality standards.

Guarantee

Certifying our products to meet European & US Pharmacopoeias (USP/EP) as well as biocompatibility testing to certify USP Class VI.

Service

Aligning our Quality System with the Good Manufacturing Practices required by the industry.

A growing and versatile range of 
30 multiproduct grades

grades  PP HOMO

7  grades  PP RANDOM

1  grades  PP HETEROPHASIC

5  grades  LDPE

4  grades  HDPE

5  grades  EVA COPOLYMERS

CONTACT INFORMATION

REPSOL

Mendez Álvaro, 44

28045 Madrid (Spain)

Tel.: +34 91 75 31 803

sacrq@repsol.com

chemicalsonline.repsol.com

Go to article: Home | A suture for the global physician shortage?Go to article: Editor's letterGo to article: ContentsGo to article: Watlow Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Bellridge Company InsightGo to article: In DepthGo to article: GenAI in radiology: a suture for the global physician shortage?Go to article: Video games as medical tools – levelling up healthcare?Go to article: The EU MDR: an unalloyed disaster?Go to article: Facing the cyberstorm: essential security strategies for medical devices Go to article: Next-generation soft robotics for smart healthcare applications Go to article: Alleima Company InsightGo to article: AlleimaGo to article: Thematic Take: AIGo to article: Thematic Take: contentsGo to article: Foreword: Generative AI as a force of creative destructionGo to article: The road to advanced AI capabilitiesGo to article: AI technology: Market size and growth forecasts Go to article: Timeline: a history of AIGo to article: The impact of AI on the medical devices sector Go to article: Case studies: AI in medical devicesGo to article: Latest news: AI in medical devicesGo to article: AI boom set to revolutionise healthcare in EuropeGo to article: How NVIDIA grew with the healthcare market instead of pushing into itGo to article: AI-driven telemedicine: emerging trends in 2024 Go to article: How Owkin trained its AI on tissue data without having any tissue or data Go to article: AI-powered precision medicine: transforming patient safety in healthcare Go to article: Roche’s new continuous glucose monitor offers AI management for diabetic patients Go to article: GE acquires software from Ultrasound AI to advance future development Go to article: Resist temptation to rapidly roll out AI – executives must focus on talent and trainingGo to article: Is AI really helping employees?Go to article: Is your business ready for the rise of AI agents?Go to article: Deal activity related to AI in the medical industry since 2021  Go to article: Repsol Go to article: Sponsored supplementsGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: mdi ConsultantsGo to article: Next issue